Cellular Oncology

Papers
(The TQCC of Cellular Oncology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Angiogenesis as a hallmark of solid tumors - clinical perspectives99
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities70
Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy67
The role of ErbB4 in cancer60
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN60
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles59
PFKP is highly expressed in lung cancer and regulates glucose metabolism52
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications52
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance46
Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update42
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications42
Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation40
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma38
CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-14538
CXCL-10: a new candidate for melanoma therapy?34
The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration33
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis30
Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma30
A comprehensive review of SHP2 and its role in cancer28
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities28
Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer26
[10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models26
Non-coding RNAs underlying chemoresistance in gastric cancer25
HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers25
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer25
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment25
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers25
Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma24
IL-17A and IL-17F orchestrate macrophages to promote lung cancer24
Functional and metabolic targeting of natural killer cells to solid tumors24
LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer23
Protein arginine methyltransferase 5: a potential cancer therapeutic target23
Clinical perspectives of BET inhibition in ovarian cancer22
The Duchenne muscular dystrophy gene and cancer21
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms21
Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression21
Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation21
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells21
The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary21
EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway21
Circular RNA circNFATC3 acts as a miR-9-5p sponge to promote cervical cancer development by upregulating SDC221
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy20
HDAC6: A unique HDAC family member as a cancer target20
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing19
Cancer‐associated fibroblasts secrete hypoxia‐induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway19
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin19
Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma19
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers18
Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory molecules18
A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma17
RETRACTED ARTICLE: Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis17
Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity17
Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis17
Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors17
Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation17
Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications17
Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation17
Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer16
Long non‐coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p16
Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma16
Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging16
WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway16
The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis16
Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer15
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment15
Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity15
LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity15
Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A15
How VEGF-A and its splice variants affect breast cancer development – clinical implications15
LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway15
Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression15
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia14
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel14
Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway14
The impact of mitochondria on cancer treatment resistance14
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling14
RETRACTED ARTICLE: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer14
Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction14
Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation14
LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA614
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models13
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer13
Organoid technology for personalized pancreatic cancer therapy13
In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer13
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer13
Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level13
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas13
Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach13
UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells13
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer12
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition12
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers12
RETRACTED ARTICLE: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling12
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway12
Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion12
Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer11
Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor11
Role of the bone microenvironment in bone metastasis of malignant tumors - therapeutic implications11
Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications11
Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy11
Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer11
IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer11
Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA10
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets10
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS10
SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α10
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models10
NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells10
Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway10
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer10
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation10
0.021389007568359